RAFAEL HOLDINGS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
RAFAEL HOLDINGS, INC. (RFL) reported Adjustments to Additional Paid in Capital, Warrant Issued of $472.00 thousand for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2025-10-29
- RAFAEL HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-04-30 was $472.00K.
- RAFAEL HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-04-30 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-01-31 was $0.00.
- RAFAEL HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $472.00K.
- RAFAEL HOLDINGS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $2.00M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2025-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $472.00K derived: sum of 2 quarters · filed 2025-10-29 | $472.00K 10-K · filed 2025-10-29 | |
| 2025-04-30 | $472.00K 10-Q · filed 2025-06-11 | $472.00K 10-Q · filed 2025-06-11 | ||
| 2022-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $0.00 derived: sum of 2 quarters · filed 2023-06-13 | $5.00M 10-Q · filed 2023-06-13 | $5.00M derived: sum of 4 quarters · filed 2023-06-13 |
| 2022-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $5.00M 10-Q · filed 2023-03-14 | $5.00M derived: sum of 3 quarters · filed 2023-03-14 | $7.00M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-10-31 | $5.00M 10-Q · filed 2022-12-13 | $5.00M derived: sum of 2 quarters · filed 2022-12-13 | $7.00M derived: sum of 3 quarters · filed 2022-12-13 | |
| 2021-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $2.00M derived: sum of 2 quarters · filed 2022-10-31 | $2.00M 10-K · filed 2022-10-31 | |
| 2021-04-30 | $2.00M 10-Q · filed 2022-06-14 | $2.00M 10-Q · filed 2022-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |